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Abstract Tightly regulated Ca2+ homeostasis is a prerequisite for proper cardiac function.  
To dissect the regulatory network of cardiac Ca2+ handling, we performed a chemical suppressor 
screen on zebrafish tremblor embryos, which suffer from Ca2+ extrusion defects. Efsevin was 
identified based on its potent activity to restore coordinated contractions in tremblor. We  
show that efsevin binds to VDAC2, potentiates mitochondrial Ca2+ uptake and accelerates the 
transfer of Ca2+ from intracellular stores into mitochondria. In cardiomyocytes, efsevin restricts 
the temporal and spatial boundaries of Ca2+ sparks and thereby inhibits Ca2+ overload-induced 
erratic Ca2+ waves and irregular contractions. We further show that overexpression of VDAC2 
recapitulates the suppressive effect of efsevin on tremblor embryos whereas VDAC2 deficiency 
attenuates efsevin's rescue effect and that VDAC2 functions synergistically with MCU to 
suppress cardiac fibrillation in tremblor. Together, these findings demonstrate a critical 
modulatory role for VDAC2-dependent mitochondrial Ca2+ uptake in the regulation of cardiac 
rhythmicity.
DOI: 10.7554/eLife.04801.001
Introduction
During development, well-orchestrated cellular processes guide cells from diverse lineages to 
integrate into the primitive heart tube and establish rhythmic and coordinated contractions. While 
many genes and pathways important for cardiac morphogenesis have been identified, molecular 
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mechanisms governing embryonic cardiac rhythmicity are poorly understood. The findings that Ca2+ 
waves traveling across the heart soon after the formation of the primitive heart tube (Chi et al., 
2008) and that loss of function of key Ca2+ regulatory proteins, such as the L-type Ca2+ channel, 
Na/K−ATPase and sodium-calcium exchanger 1 (NCX1), severely impairs normal cardiac function 
(Rottbauer et al., 2001; Shu et al., 2003; Ebert et al., 2005; Langenbacher et al., 2005), indicate 
an essential role for Ca2+ handling in the regulation of embryonic cardiac function.
Ca2+ homoeostasis in cardiac muscle cells is tightly regulated at the temporal and spatial level by 
a subcellular network involving multiple proteins, pathways, and organelles. The release and reup-
take of Ca2+ by the sarcoplasmic reticulum (SR), the largest Ca2+ store in cardiomyocytes, constitutes 
the primary mechanism governing the contraction and relaxation of the heart. Ca2+ influx after acti-
vation of the L-type Ca2+ channel in the plasma membrane induces the release of Ca2+ from the SR 
via ryanodine receptor (RyR) channels, which leads to an increase of the intracellular Ca2+ concentra-
tion and cardiac contraction. During diastolic relaxation, Ca2+ is transferred back into the SR by the 
SR Ca2+ pump or extruded from the cell through NCX1. Defects in cardiac Ca2+ handling and Ca2+ 
overload, for example during cardiac ischemia/reperfusion or in long QT syndrome, are well known 
causes of contractile dysfunction and many types of arrhythmias including early and delayed after-
depolarizations and Torsade des pointes (Bers, 2002; Choi et al., 2002; Yano et al., 2008; Greiser 
et al., 2011).
Ca2+ crosstalk between mitochondria and ER/SR has been noted in many cell types and the voltage-
dependent anion channel (VDAC) and the mitochondrial Ca2+ uniporter (MCU) serve as primary routes 
for Ca2+ entry through the outer and inner mitochondrial membranes, respectively (Rapizzi et al., 
2002; Bathori et al., 2006; Shoshan-Barmatz et al., 2010; Baughman et al., 2011; De Stefani et al., 
2011). In the heart, mitochondria are tethered to the SR and are located in close proximity to Ca2+ 
release sites (García-Pérez et al., 2008; Boncompagni et al., 2009; Hayashi et al., 2009). This subcel-
lular architecture exposes the mitochondria near the Ca2+ release sites to a high local Ca2+ concentration 
eLife digest The heart is a large muscle that pumps blood around the body by maintaining a 
regular rhythm of contraction and relaxation. If the heart loses this regular rhythm it works less 
efficiently, which can lead to life-threatening conditions.
Regular heart rhythms are maintained by changes in the concentration of calcium ions in the 
cytoplasm of the heart muscle cells. These changes are synchronised so that the heart cells contract 
in a controlled manner. In each cell, a contraction begins when calcium ions from outside the cell 
enter the cytoplasm by passing through a channel protein in the membrane that surrounds the 
cell. This triggers the release of even more calcium ions into the cytoplasm from stores within the 
cell. For the cells to relax, the calcium ions must then be pumped out of the cytoplasm to lower 
the calcium ion concentration back to the original level.
Shimizu et al. studied a zebrafish mutant—called tremblor—that has irregular heart rhythms 
because its heart muscle cells are unable to efficiently remove calcium ions from the cytoplasm. 
Embryos of the tremblor mutant were treated with a wide variety of chemical compounds with the 
aim of finding some that could correct the heart defect.
A compound called efsevin restores regular heart rhythms in tremblor mutants. Efsevin binds to 
a pump protein called VDAC2, which is found in compartments called mitochondria within the cell. 
Although mitochondria are best known for their role in supplying energy for the cell, they also act 
as internal stores for calcium. By binding to VDAC2, efsevin increases the rate at which calcium ions 
are pumped from the cytoplasm into the mitochondria. This restores rhythmic calcium ion cycling in 
the cytoplasm and enables the heart muscle cells to develop regular rhythms of contraction and 
relaxation. Increasing the levels of VDAC2 or another similar calcium ion pump protein in the heart 
cells can also restore a regular heart rhythm.
Efsevin can also correct irregular heart rhythms in human and mouse heart muscle cells, therefore 
the new role for mitochondria in controlling heart rhythms found by Shimizu et al. appears to be 
shared in other animals. The experiments have also identified the VDAC family of proteins as 
potential new targets for drug therapies to treat people with irregular heart rhythms.
DOI: 10.7554/eLife.04801.002
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that is sufficient to overcome the low Ca2+ affinity of MCU and facilitates Ca2+ crosstalk between SR 
and mitochondria (García-Pérez et al., 2008; Dorn and Scorrano, 2010; Kohlhaas and Maack, 2013). 
Increase of the mitochondrial Ca2+ concentration enhances energy production during higher workload and 
dysregulation of SR-mitochondrial Ca2+ signaling results in energetic deficits and oxidative stress in the 
heart and may trigger programmed cell death (Brandes and Bers, 1997; Maack et al., 2006; Kohlhaas 
and Maack, 2013). However, whether SR-mitochondrial Ca2+ crosstalk also contributes significantly to 
cardiac Ca2+ signaling during excitation-contraction coupling requires further investigation.
In zebrafish, the tremblor (tre) locus encodes a cardiac-specific isoform of the Na+/Ca2+ exchanger 1, 
NCX1h (also known as slc8a1a) (Ebert et al., 2005; Langenbacher et al., 2005). The tre mutant hearts 
Figure 1. Efsevin restores rhythmic cardiac contractions in zebrafish tremblor embryos. (A) Line scans across the atria of Tg(myl7:GFP) embryonic hearts 
at 48 hpf. Rhythmically alternating systoles and diastoles are recorded from vehicle- (upper left) or efsevin- treated wild type (upper right) and efsevin-
treated tre (lower right) embryos, while only sporadic unsynchronized contractions are recorded from vehicle-treated tre embryos (lower left). (B, C) 
Fractional shortening (FS) deduced from the line-scan traces. While cardiac contraction was not observed in tre, efsevin-treated wild type and tre hearts 
have similar levels of FS to those observed in control hearts. Ventricular FS of wild type v.s. wild type + efsevin vs tre + efsevin: 39 ± 0.6%, n = 8 vs 39 ± 1%,  
n = 10 vs 35 ± 3%, n = 6; and Atrial FS: 37 ± 1%, n = 11 vs 35 ± 2%, n = 11 vs 33 ± 2%, n = 15. (D) While efsevin restored a heart rate of 46 ± 2 beats 
per minute (bpm) in tre embryos, same treatment does not affect the heart rate in wild type embryos (126 ± 2 bpm in vehicle-treated embryos vs  
123 ± 3 bpm in efsevin-treated wild-type embryos). ***, p < 0.001 by one-way ANOVA. (E) Dose-dependence curve for efsevin. The tre embryos were 
treated with various concentrations of efsevin from 24 hpf and cardiac contractions were analyzed at 48 hpf. (F–H) Representative time traces of local 
field potentials for wild type (F), tre (G) and efsevin-treated tre (H) embryos clearly display periods of regular, irregular, and restored periodic electrical 
activity. (I) In vivo optical maps of Ca2+ activation represented by isochronal lines every 33 ms recorded from 36 hpf wild type (left), tre (center) and 
efsevin-treated tre (right) embryos.
DOI: 10.7554/eLife.04801.003
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lack rhythmic Ca2+ transients and display chaotic 
Ca2+ signals in the myocardium leading to unsyn-
chronized contractions resembling cardiac fibril-
lation (Langenbacher et al., 2005). In this study, 
we used tre as an animal model for aberrant Ca2+ 
handling-induced cardiac dysfunction and took 
a chemical genetic approach to dissect the Ca2+ 
regulatory network important for maintaining car-
diac rhythmicity. A synthetic compound named 
efsevin was identified from a suppressor screen 
due to its potent ability to restore coordinated 
contractions in tre. Using biochemical and genetic 
approaches we show that efsevin interacts with 
VDAC2 and potentiates its mitochondrial Ca2+ 
transporting activity and spatially and tempo-
rally modulates cytosolic Ca2+ signals in cardio-
myocytes. The important role of mitochondrial 
Ca2+ uptake in regulating cardiac rhythmicity is 
further supported by the suppressive effect of 
VDAC2 and MCU overexpression on cardiac fibril-
lation in tre.
Results and discussion
Identification of a chemical 
suppressor of tre cardiac 
dysfunction
Homozygous tre mutant embryos suffer from Ca2+ 
extrusion defects and manifest chaotic cardiac 
contractions resembling fibrillation (Ebert et al., 
2005; Langenbacher et al., 2005). To dissect 
the regulatory network of Ca2+ handling in car-
diomyocytes and to identify mechanisms control-
ling embryonic cardiac rhythmicity, we screened 
the BioMol library and a collection of synthetic 
compounds for chemicals that are capable of 
restoring heartbeat either completely or partially 
in tre embryos. A dihydropyrrole carboxylic ester 
compound named efsevin was identified based 
on its ability to restore persistent and rhythmic 
cardiac contractions in tre mutant embryos in 
a dose-dependent manner (Figure 1A,E, and 
Videos 1–4). To validate the effect of efsevin, we 
assessed cardiac performance of wild type, tre 
and efsevin-treated tre embryos (Nguyen et al., 
2009). Fractional shortening of efsevin treated 
tre mutant hearts was comparable to that of their 
wild type siblings and heart rate was restored 
to approximately 40% of that observed in con-
trols (Figure 1B–D). Periodic local field potentials 
accompanying each heartbeat were detected in 
wild type and efsevin-treated tre embryos using a microelectrode array (Figure 1F–H). Furthermore, 
while only sporadic Ca2+ signals were detected in tre hearts, in vivo Ca2+ imaging revealed steady 
Ca2+ waves propagating through efsevin-treated tre hearts (Figure 1I, Videos 5–7), demonstrating 
that cardiomyocytes are functionally coupled and that efsevin treatment restores regular Ca2+ tran-
sients in tre hearts.
Video 1. The video shows a heart of a wild-type 
zebrafish embryo at 2 dpf. Robust rhythmic contractions 
can be observed in atrium and ventricle.
DOI: 10.7554/eLife.04801.004
Video 2. This video shows a heart of a tremblor embryo 
at 2 dpf. Embryos of the mutant line tremblor display 
only local, unsynchronized contractions, comparable to 
cardiac fibrillation.
DOI: 10.7554/eLife.04801.005
Video 3. This video shows a heart of a tremblor embryo 
at 2 dpf treated with efsevin. Treatment of tremblor 
embryos with efsevin restores rhythmic contractions 
with comparable atrial fractional shortening compared 
to wild-type embryos and approximately 40% of 
wild-type heart rate.
DOI: 10.7554/eLife.04801.006
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Efsevin suppresses Ca2+  
overload-induced irregular 
contraction
We next examined whether efsevin could suppress 
aberrant Ca2+ homeostasis-induced arrhythmic 
responses in mammalian cardiomyocytes. Mouse 
embryonic stem cell-derived cardiomyocytes 
(mESC-CMs) establish a regular contraction pattern 
with rhythmic Ca2+ transients (Figure 2A,B,E,F). 
Mimicking Ca2+ overload by increasing extracel-
lular Ca2+ levels was sufficient to disrupt normal 
Ca2+ cycling and induce irregular contractions in 
mESC-CMs (Figure 2C,E,F). Remarkably, efsevin 
treatment restored rhythmic Ca2+ transients and 
cardiac contractions in these cells (Figure 2D–F). 
Similar effect was observed in human embryonic 
stem cell-derived cardiomyocytes (hESC-CMs) 
(Figure 2G). Together, these findings suggest 
that efsevin targets a conserved Ca2+ regulatory 
mechanism critical for maintaining rhythmic car-
diac contraction in fish, mice and humans.
VDAC2 mediates the suppressive 
effect of efsevin on tre
To identify the protein target of efsevin, we gen-
erated a N-Boc-protected 2-aminoethoxyeth-
oxyethylamine linker-attached efsevin (efsevinL) 
(Figure 3A,C). This modified compound retained 
the activity of efsevin to restore cardiac contrac-
tions in ncx1h deficient embryos (Figure 3B,D) and 
was used to create efsevin-conjugated agarose 
beads (efsevinLB). A 32kD protein species was 
detected from zebrafish lysate due to its binding 
ability to efsevinLB and OK-C125LB, an active efsevin 
derivative conjugated to beads, but not to beads 
capped with ethanolamine alone or beads conju-
gated with an inactive efsevin analog (OK-C19LB) 
(Figure 3A–E). Furthermore, preincubation of 
zebrafish lysate with excess efsevin prevented 
the 32kD protein from binding to efsevinLB or 
OK-C125LB (Figure 3E). Mass spectrometry anal-
ysis revealed that this 32kD band represents a 
zebrafish homologue of the mitochondrial voltage-dependent anion channel 2 (VDAC2) (Figure 3F 
and Figure 3—figure supplement 1).
VDAC2 is expressed in the developing zebrafish heart (Figure 4A), making it a good candidate for 
mediating efsevin’s effect on cardiac Ca2+ handling. To examine this possibility, we injected in vitro 
synthesized VDAC2 RNA into tre embryos and found that the majority of these embryos had coordi-
nated cardiac contractions similar to those subjected to efsevin treatment (Figure 4B, Videos 8–11). 
In addition, we generated myl7:VDAC2 transgenic fish in which VDAC2 expression can be induced in 
the heart by tebufenozide (TBF) (Figure 4C). Knocking down NCX1h in myl7:VDAC2 embryos results 
in chaotic cardiac movement similar to tre. Like efsevin treatment, induction of VDAC2 expression by 
TBF treatment restored coordinated and rhythmic contractions in myl7:VDAC2;NCX1h MO hearts 
(Figure 4D, Videos 12,13). Conversely, knocking down VDAC2 in tre hearts attenuated the suppres-
sive effect of efsevin (Figure 4E, Videos 14–16). Furthermore, we generated VDAC2 null embryos by 
the Zinc Finger Nuclease gene targeting approach (Figure 4G). Similar to that observed in morpholino 
knockdown embryos, homozygous VDAC2LA2256 embryos do not exhibit noticeable morphological 
Video 4. The video shows a heart of a wild-type 
zebrafish embryo at 2 dpf treated with efsevin. 
Treatment of wild-type embryos with efsevin did not 
affect cardiac performance, indicated by robust, 
rhythmic contractions comparable to untreated 
wild-type embryos.
DOI: 10.7554/eLife.04801.007
Video 5. Heat map of Ca2+ transients recorded in 1 day 
old wild type heart. 
DOI: 10.7554/eLife.04801.008
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defects, but the suppressive effect of efsevin was 
attenuated in homozygous VDAC2LA2256; NCX1MO 
embryos (Figure 4F). These findings demonstrate 
that VDAC2 is a major mediator for efsevin’s effect 
on ncx1h deficient hearts.
VDAC2-dependent effect of 
efsevin on mitochondrial Ca2+ 
uptake
VDAC is an abundant channel located on the 
outer mitochondrial membrane serving as a primary 
passageway for metabolites and ions (Figure 5A) 
(Rapizzi et al., 2002; Bathori et al., 2006; 
Shoshan-Barmatz et al., 2010). At its close state, 
VDAC favours Ca2+ flux (Tan and Colombini, 2007). 
To examine whether efsevin would modulate mito-
chondrial Ca2+ uptake via VDAC2, we transfected 
HeLa cells with VDAC2. We noted increased mito-
chondrial Ca2+ uptake in permeabilized VDAC2 
transfected and efsevin-treated cells after the addi-
tion of Ca2+ and the combined treatment further 
enhanced mitochondrial Ca2+ levels (Figure 5B).
Mitochondria are located in close proximity 
to Ca2+ release sites of the ER/SR and an exten-
sive crosstalk between the two organelles exists 
(García-Pérez et al., 2008; Hayashi et al., 2009; 
Brown and O'Rourke, 2010; Dorn and Scorrano, 
2010; Kohlhaas and Maack, 2013). We examined 
whether Ca2+ released from intracellular stores 
could be locally transported into mitochondria 
through VDAC2 in VDAC1/VDAC3 double knock-
out (V1/V3DKO) MEFs where VDAC2 is the 
only VDAC isoform being expressed (Roy et al., 
2009a). While treatments with ATP, an IP3-linked 
agonist, and thapsigargin, a SERCA inhibitor, 
stimulated similar global cytoplasmic [Ca2+] ele-
vation in intact cells, only ATP induced a rapid 
mitochondrial matrix [Ca2+] rise (Figure 5—figure 
supplement 1). This finding is consistent with 
observations obtained in other cell types (Rizzuto 
et al., 1994; Hajnóczky et al., 1995) and sug-
gests that Ca2+ was locally transferred from IP3 
receptors to mitochondria through VDAC2 at 
the close ER-mitochondrial associations. We next 
investigated whether this process could be mod-
ulated by efsevin. In permeabilized V1/V3DKO 
MEFs, treatment with efsevin increased the 
amount of Ca2+ transferred into mitochondria 
during IP3-induced Ca2+ release (Figure 5C). Also, in intact V1/V3 DKO MEFs, efsevin accelerated 
the transfer of Ca2+ released from intracellular stores into mitochondria during stimulation with ATP 
(Figure 5D,E).
Efsevin modulates Ca2+ sparks and suppresses erratic Ca2+ waves in 
cardiomyocytes
We next examined the effect of efsevin on cytosolic Ca2+ signals in isolated adult murine cardiomyo-
cytes. We found that efsevin treatment induced faster inactivation kinetics without affecting the 
Video 6. Heat map of Ca2+ transients recorded in 1 day 
old tremblor heart. 
DOI: 10.7554/eLife.04801.009
Video 7. Heat map of Ca2+ transients recorded in 1 day 
old efsevin treated tremblor heart. 
DOI: 10.7554/eLife.04801.010
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amplitude or time to peak of paced Ca2+ transients (Figure 6A). Similarly, efsevin treatment did not signif-
icantly alter the frequency, amplitude or Ca2+ release flux of spontaneous Ca2+ sparks, local Ca2+ release 
events, but accelerated the decay phase resulting in sparks with a shorter duration and a narrower 
width (Figure 6B). These results indicate that by activating mitochondrial Ca2+ uptake, efsevin acceler-
ates Ca2+ removal from the cytosol in cardiomyocytes and thereby restricts local cytosolic Ca2+ sparks 
to a narrower domain for a shorter period of time without affecting SR Ca2+ load or RyR Ca2+ release. 
Under conditions of Ca2+ overload, single Ca2+ sparks can trigger opening of neighbouring Ca2+ release 
units and thus induce the formation of erratic Ca2+ waves (Figure 6C). Efsevin treatment significantly 
reduced the number of propagating Ca2+ waves in a dosage-dependent manner (Figure 6C,D), demon-
strating a potent suppressive effect of efsevin on the propagation of Ca2+ overload-induced Ca2+ waves 
and suggesting that efsevin could serve as a pharmacological tool to manipulate local Ca2+ signals.
Figure 2. Efsevin reduces arrhythmogenic events in ES cell-derived cardiomyocytes. (A) Line-scan analysis of 
Ca2+ transients in mESC-CMs after 10 days of differentiation. (B–D) Representative graph of Ca2+ transients 
detected in mESC-CMs (B). After treatment with 10 mM Ca2+ for 10 min, the EB showed an irregular pattern of 
Ca2+ transients (C). Efsevin treatment restores regular Ca2+ transients under Ca2+ overload conditions in mESC-CMs  
(D). (E) Plotted intervals between peaks of Ca2+ signals detected in mESC-CMs prior to treatment (control), in  
10 mM Ca2+ext (Ca2+) and in 10 mM Ca2+ext+10 μM efsevin (Ca2++efsevin). (F, G) Plotted intervals of contractions 
detected in EBs prior to treatment (control), in 10 mM Ca2+ext (Ca2+) and in 10 mM Ca2+ext + 10 μM efsevin  
(Ca2+ + efsevin) for mouse ESC-CMs (F) and 5 mM Ca2+ext (Ca2+) and in 5 mM Ca2+ext + 5 μM efsevin (Ca2+ + efsevin) 
for human ESC-CMs (G). ***, p < 0.001 by F-test.
DOI: 10.7554/eLife.04801.011
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Mitochondrial Ca2+ uptake modulates embryonic cardiac rhythmicity
We hypothesize that efsevin treatment/VDAC2 overexpression suppresses aberrant Ca2+ handling-
associated arrhythmic cardiac contractions by buffering excess Ca2+ into mitochondria. This hypo-
thesis predicts that activating other mitochondrial Ca2+ uptake molecules would likewise restore 
coordinated contractions in tre. To test this model, we cloned zebrafish MCU and MICU1, an inner 
mitochondrial membrane Ca2+ transporter and its regulator (Perocchi et al., 2010; Baughman et al., 
2011; De Stefani et al., 2011; Mallilankaraman et al., 2012; Csordas et al., 2013). In situ hybrid-
ization showed that MCU and MICU1 were expressed in the developing zebrafish heart (Figure 7A) 
and their expression levels were comparable between the wild type and tre hearts (Figure 7—figure 
supplement 1). Overexpression of MCU restored coordinated contractions in tre, akin to what was 
observed with VDAC2 (Figure 7B). In addition, tre embryos injected with suboptimal concentra-
tions of MCU or VDAC2 had a fibrillating heart, but embryos receiving both VDAC2 and MCU at 
the suboptimal concentration manifested coordinated contractions (Figure 7C), demonstrating a 
synergistic effect of these proteins. Furthermore, overexpression of MCU failed to suppress the tre 
phenotype in the absence of VDAC2 activity and VDAC2 could not restore coordinated contrac-
tions in tre without functional MCU (Figure 7B,D). Similar results were observed by manipulating 
MICU1 activity (Figure 7E,F). Together, these findings indicate that mitochondrial Ca2+ uptake 
mechanisms on outer and inner mitochondrial membranes act cooperatively to regulate cardiac 
rhythmicity.
Conclusion
In summary, we conducted a chemical suppressor screen in zebrafish to dissect the regulatory network 
critical for maintaining rhythmic cardiac contractions and to identify mechanisms underlying aberrant 
Figure 3. VDAC2 is a protein target of efsevin. (A) Structures of efsevin and two derivatives, OK-C125 and OK-C19. (B) Efsevin and OK-C125 restored 
rhythmic contractions in the majority of tremblor embryos, whereas OK-C19 failed to rescue the tremblor phenotype. (C) Structures of linker-attached 
compounds (indicated by superscript L). (D) Compounds efsevinL and OK-C125L retained their ability to restore rhythmic contractions in NCX1hMO 
injected embryos, while the inactive derivative OK-C19L was still unable to induce rhythmic contraction. (E) Affinity agarose beads covalently linked  
with efsevin (efsevinLB) or OK-C125 (OK-C125LB) pulled down 2 protein species from zebrafish embryonic lysate, whereof one, the 32 kD upper band, was 
sensitive to competition with a 100-fold excess free efsevinL. The 32 kD band was not detected in proteins eluted from beads capped with ethanolamine 
alone (beadsC) or beads linked to OK-C19 (OK-C19LB). Arrowheads point to the 32kD bands. (F) Mass Spectrometry identifies the 32kD band as VDAC2. 
Peptides identified by mass spectrometry (underlined) account for 30% of the total sequence.
DOI: 10.7554/eLife.04801.012
The following figure supplement is available for figure 3:
Figure supplement 1. Mass Spectometry identifies VDAC2 as the target of efsevin. 
DOI: 10.7554/eLife.04801.013
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Ca2+ handling-induced cardiac dysfunction. We 
show that activation of VDAC2 through overex-
pression or efsevin treatment potently restores 
rhythmic contractions in NCX1h deficient zebrafish 
hearts and effectively suppresses Ca2+ over-
load-induced arrhythmogenic Ca2+ events and 
irregular contractions in mouse and human cardi-
omyocytes. We provide evidence that potentiat-
ing VDAC2 activity enhances mitochondrial Ca2+ 
uptake, accelerates Ca2+ transfer from intracel-
lular stores into mitochondria and spatially and 
temporally restricts single Ca2+ sparks in cardio-
myocytes. The crucial role of mitochondria in the 
regulation of cardiac rhythmicity is further sup-
ported by the findings that VDAC2 functions in 
concert with MCU; these genes have a strong synergistic effect on suppressing cardiac fibrillation and 
loss of function of either gene abrogates the rescue effect of the other in tre.
Figure 4. VDAC2 restores rhythmic cardiac contractions in tre. (A) In situ hybridization analysis showed that VDAC2 is expressed in embryonic hearts at 
36 hpf (upper image) and 48 hpf (lower image). (B) Injection of 25 pg in vitro synthesized VDAC2 mRNA restored cardiac contractions in 52.9 ± 12.1%  
(n = 78) of 1-day-old tre embryos, compared to 21.8 ± 5.1% in uninjected siblings (n = 111). (C) Schematic diagram of myl7:VDAC2 construct (top). In situ 
hybridization analysis showed that TBF treatment induces VDAC2 expression in the heart (lower panel). (D) While only ∼20% of myl7:VDAC2;NCX1hMO 
embryos have coordinated contractions (n = 116), 52.3 ± 2.4% of these embryos established persistent, rhythmic contractions after TBF induction of 
VDAC2 (n = 154). (E) On average, 71.2 ± 8.8% efsevin treated embryos have coordinated cardiac contractions (n = 131). Morpholino antisense oligonu-
cleotide knockdown of VDAC2 (MOVDAC2) attenuates the ability of efsevin to suppress cardiac fibrillation in tre embryos (45.3 ± 7.4% embryos with 
coordinated contractions, n = 94). (F) Efsevin treatment restores coordinated cardiac contractions in 76.2 ± 8.7% NCX1MO embryos, only 54.1 ± 3.6% 
VDAC2zfn/zfn;NCX1MO embryos have coordinated contractions (n = 250). (G) Diagram of Zinc finger target sites. VDAC2zfn/zfn carries a 34 bp deletion in 
exon 3 which results in a premature stop codon (red asterisk). In situ hybridization analysis showing loss of VDAC2 transcripts in VDAC2zfn/zfn embryos. 
White arrowheads point to the developing heart.
DOI: 10.7554/eLife.04801.014
Video 8. This video shows a heart of a wild-type 
zebrafish embryo at 1 dpf. Robust rhythmic contractions 
can be observed in atrium and ventricle.
DOI: 10.7554/eLife.04801.015
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The regulatory roles of mitochondrial Ca2+ in 
cardiac metabolism, cell survival and fate have 
been studied extensively (Brown and O'Rourke, 
2010; Dorn and Scorrano, 2010; Doenst et al., 
2013; Kasahara et al., 2013; Kohlhaas and 
Maack, 2013; Luo and Anderson, 2013). Our 
study provides genetic and physiologic evidence 
supporting an additional role for mitochondria in 
regulating cardiac rhythmicity and reveals VDAC2 
as a modulator of Ca2+ handling in cardiomyo-
cytes. Our findings, together with recent reports 
of the physical interaction between VDAC2 and 
RyR2 (Min et al., 2012) and the close proximity 
of outer and inner mitochondrial membranes at 
the contact sites between the mitochondria and 
the SR (García-Pérez et al., 2011), suggest an 
intriguing model. We propose that mitochondria 
facilitate an efficient clearance mechanism in the 
Ca2+ microdomain, which modulates Ca2+ hand-
ling without affecting global Ca2+ signals in car-
diomyocytes. In this model, VDAC facilitates 
mitochondrial Ca2+ uptake via MCU complex and 
thereby controls the duration and the diffusion 
of cytosolic Ca2+ near the Ca2+ release sites to 
ensure rhythmic cardiac contractions. This model 
is consistent with our observation that efsevin 
treatment induces faster inactivation kinetics of 
cytosolic Ca2+ transients without affecting the 
amplitude or the time to peak in cardiomyocytes 
and the reports that blocking mitochondrial Ca2+ 
uptake has little impact on cytosolic Ca2+ tran-
sients (Maack et al., 2006; Kohlhaas et al., 
2010). Further support for this model comes from 
the observation of the Ca2+ peaks on the OMM 
(Drago et al., 2012) and the finding that down-
regulating VDAC2 extends Ca2+ sparks (Subedi 
et al., 2011; Min et al., 2012) and that blocking 
mitochondrial Ca2+ uptake by Ru360 leads to an 
increased number of spontaneous propagating 
Ca2+ waves (Seguchi et al., 2005). Future studies 
on the kinetics of VDAC2-dependent mitochon-
drial Ca2+ uptake and exploring potential regula-
tory molecules for VDAC2 activity will provide 
insights into how the crosstalk between SR and 
mitochondria contributes to Ca2+ handling and 
cardiac rhythmicity.
Aberrant Ca2+ handling is associated with 
many cardiac dysfunctions including arrhythmia. 
Establishing animal models to study molecular 
mechanisms and develop new therapeutic strategies are therefore major preclinical needs. Our chem-
ical suppressor screen identified a potent effect of efsevin and its biological target VDAC2 on manipu-
lating cardiac Ca2+ handling and restoring regular cardiac contractions in fish and mouse and human 
cardiomyocytes. This success indicates that fundamental mechanisms regulating cardiac function are 
conserved among vertebrates despite the existence of species-specific features and suggests a new 
paradigm of using zebrafish cardiac disease models for the dissection of critical genetic pathways and 
the discovery of new therapeutic approaches. Future studies examining the effects of efsevin on other 
Video 9. This video shows a heart of a wild-type 
zebrafish embryo injected with zebrafish VDAC2 mRNA 
at 1 dpf. Robust rhythmic contractions can be observed 
in atrium and ventricle.
DOI: 10.7554/eLife.04801.016
Video 10. This video shows a heart of a tremblor 
embryo at 1 dpf. Tremblor embryos display only local, 
unsynchronized contractions, comparable to cardiac 
fibrillation.
DOI: 10.7554/eLife.04801.017
Video 11. This video shows a heart of a tremblor 
embryo injected with zebrafish VDAC2 mRNA at 1 dpf. 
Overexpression of zebrafish VDAC2 mRNA restores 
rhythmic contractions in tremblor embryos.
DOI: 10.7554/eLife.04801.018
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arrhythmia models would further elucidate the 
potential for efsevin as a pharmacological tool to 
treat cardiac arrhythmia associated with aberrant 
Ca2+ handling.
Materials and methods
Zebrafish husbandry and 
transgenic lines
Zebrafish of the mutant line tremblor (tretc318) 
were maintained and bred as described previ-
ously (Langenbacher et al., 2005). Transgenic 
lines, myl7:gCaMP4.1LA2124 and myl7:VDAC2LA2309 
were created using the Tol2kit (Esengil et al., 
2007; Kwan et al., 2007; Shindo et al., 2010). 
The VDAC2LA2256 was created using the zinc fin-
ger array OZ523 and OZ524 generated by the 
zebrafish Zinc Finger Consortium (Foley et al., 
2009a, 2009b).
Molecular Biology
Full length VDAC2 cDNA was purchased from 
Open Biosystems (Huntsville, AL) and cloned into 
pCS2+ or pCS2+3XFLAG. Full length cDNA 
fragments of zebrafish MCU (Accession number: 
JX424822) and MICU1 (JX42823) were amplified 
from 2 dpf embryos and cloned into pCS2+. For 
mRNA synthesis, plasmids were linearized and 
mRNA was synthesized using the SP6 mMES-
SAGE mMachine kit according to the manufac-
turers manual (Ambion, Austin, TX.).
Zebrafish injections
VDAC2 mRNA and morpholino antisense oligos 
(5 ′-GGGAACGGCCATTTTATCTGTTAAA-3 ′) 
(Genetools, Philomath, OR) were injected into 
one-cell stage embryos collected from crosses of 
tretc318 heterozygotes. Cardiac performance was 
analyzed by visual inspection on 1 dpf. The tre 
mutant embryos were identified either by observ-
ing the fibrillation phenotype at 2–3 dpf or by 
genotyping as previously described (Langenbacher 
et al., 2005).
Chemical screen
Chemicals from a synthetic library (Castellano 
et al., 2007; Choi et al., 2011; Cruz et al., 2011) 
and from Biomol International LP (Farmingdale, 
NY) were screened for their ability to partially 
or completely restore persistent heartbeat in tre 
embryos. 12 embryos collected from crosses of 
tretc318 heterozygotes were raised in the presence of individual compounds at a concentration of 10 µM 
from 4 hpf (Choi et al., 2011). Cardiac function was analyzed by visual inspection at 1 and 2 dpf. The 
hearts of tretc318 embryos manifest a chaotic movement resembling cardiac fibrillation with intermittent 
contractions in rare occasion (Ebert et al., 2005; Langenbacher et al., 2005). Compounds that elicit 
persistent coordinated cardiac contractions were validated on large number of tre mutant embryos 
and NCX1h morphants (>500 embryos).
Video 12. This video shows a heart of a 2 dpf  
Tg-VDAC2 embryo injected with a morpholino 
targeting NCX1h. Morpholino knock-down of  
NCX1h results in a fibrillating heart.
DOI: 10.7554/eLife.04801.019
Video 13. This video shows a heart of a 2 dpf NCX1h 
morphant in the Tg-VDAC2 genetic background. TBF 
treatment induces VDAC2 expression and restores 
coordinated cardiac contractions.
DOI: 10.7554/eLife.04801.020
Video 14. This video shows a heart of a 2 dpf wild type 
zebrafish embryo injected with a morpholino targeting 
VDAC2. Morpholino knockdown of VDAC2 did not have 
obvious effects on cardiac performance.
DOI: 10.7554/eLife.04801.021
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Zebrafish cardiac imaging
Videos of GFP-labelled myl7:GFP hearts were 
taken at 30 frames per second. Line-scan anal-
ysis was performed along a line through the atria 
or the ventricles of these hearts (Nguyen et al., 
2009). Fraction of shortening was deduced from 
the ratio of diastolic and systolic width and heart 
rate was determined by beats per minute. Cardiac 
parameters were analyzed in tremblortc318 and 
VDAC2LA2256 at 2 dpf.
Zebrafish optical mapping
36 hpf myl7:gCaMP4.1 embryos were imaged at 
a frame rate of 30 ms/frame. Electromechanical 
isolation was achieved by tnnt2MO (Milan et al., 
2006). The fluorescence intensity of each pixel 
in a 2D map was normalize to generate heat 
maps and isochronal lines at 33 ms intervals were 
obtained by identifying the maximal spatial gra-
dient for a given time point (Chi et al., 2008).
Mouse and human embryonic  
stem cells
The mouse E14Tg2a ESC and human H9 ESC line 
were cultured and differentiated as previously 
described (Blin et al., 2010; Arshi et al., 2013). 
At day 10 of differentiation, beating mouse EBs 
were exposed to external solution containing 
10 mM CaCl2 for 10 min before DMSO or efsevin 
(10 μM) treatment. Human EBs were differenti-
ated for 15 days and treated with 5 mM CaCl2 
for 10 min before DMSO or efsevin (5 μM) treat-
ment. Images of beating EBs were acquired at a 
rate of 30 frames/s and analyzed by motion-detection software. For calcium recording, the EBs were 
loaded with 10 μM fluo-4 AM in culture media for 30 min at 37°C. Line-scan analysis was performed 
and fluorescent signals were acquired by a Zeiss LSM510 confocal microscope.
Microelectrode array measurements
2-day-old wild type, tre, and efsevin-treated tre embryos were placed on uncoated, microelectrode 
arrays (MEAs) containing 120 integrated TiN electrodes (30 μm diameter, 200 μm interelectrode spac-
ing). Local field potentials (LFPs) at each electrode were collected for three trials per embryo type over 
a period of three minutes at a sampling rate of 1 kHz using the MEA2100-HS120 system (Multichannel 
Systems, Reutiligen, Germany). Raw data was low-pass filtered at a cutoff frequency of 10 Hz using a 
third-order Butterworth filter. Data analysis was carried out using the MC_DataTool (Multichannel 
Systems) and Matlab (MathWorks).
Ca2+ imaging
Murine ventricular cardiomyocytes were isolated as previously described (Reuter et al., 2004). Cells 
were loaded with 5 µM fluo-4 AM in external solution containing: 138.2 mM NaCl, 4.6 mM KCl, 1.2 mM 
MgCl, 15 mM glucose, 20 mM HEPES for 1 hr and imaged in external solution supplemented with 
2, 5 or 10 mM CaCl2. For the recording of Ca2+ sparks and transients, the external solution contained 
2 mM CaCl2. For Ca2+ transients, cells were field stimulated at 0.5 Hz with a 5 ms pulse at a voltage 
of 20% above contraction threshold. For all measurements, efsevin was added 2 hr prior to the actual 
experiment. Images were recorded on a Zeiss LSM 5 Pascal confocal microscope. Data analysis was 
carried out using the Zeiss LSM Image Browser and ImageJ with the SparkMaster plugin (Picht et al., 
2007). Cells were visually inspected prior to and after each recording. Only those recordings from 
Video 15. This video shows a heart of a 2 dpf tremblor 
mutant embryo injected with a morpholino targeting 
VDAC2. 
DOI: 10.7554/eLife.04801.022
Video 16. This video shows a heart of a 2 dpf tremblor 
mutant embryo injected with a morpholino targeting 
VDAC2. Efsevin treatment cannot restore coordinated 
cardiac contractions in the absence of VDAC2.
DOI: 10.7554/eLife.04801.023
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Figure 5. Efsevin enhances mitochondrial Ca2+ uptake. (A) HeLa cells were transfected with a flag-tagged zebrafish 
VDAC2 (VDAC2flag), immunostained against the flag epitope and counterstained for mitochondria with MitoTracker 
Orange and for nuclei with DAPI. (B) Representative traces of mitochondrial matrix [Ca2+] ([Ca2+]m) detected by 
Figure 5. Continued on next page
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Rhod2. Arrows denote the addition of Ca2+. Mitochondrial Ca2+ uptake was assessed when VDAC2 was overex-
pressed (left), cells were treated with 1 µM efsevin (middle) and combination of both at suboptimal doses (right). 
Control-traces with ruthenium red (RuRed) show mitochondrial specificity of the signal. (C) Representative traces  
of cytosolic [Ca2+] ([Ca2+]c) changes upon the application of 7.5 µM IP3 in the presence (+) or absence (−) of RuRed. 
Mitochondrial Ca2+ uptake was assessed by the difference of the – and + RuRed conditions normalized to the 
total release (n = 4; mean ± SE). (D) MEFs overexpressing zebrafish VDAC2 (polycistronic with mCherry) were 
stimulated with 1 μM ATP in a nominally Ca2+ free buffer. Changes in [Ca2+]c and [Ca2+]m were imaged using fura2 
and mitochondria-targeted inverse pericam, respectively. Black and gray traces show the [Ca2+]c (in nM) and [Ca2+]m 
(F0/F mtpericam) time courses in the absence (left) or present (right) of efsevin. (E) Bar charts: Cell population 
averages for the peak [Ca2+]c (left), the corresponding [Ca2+]m (middle), and the coupling time (time interval between 
the maximal [Ca2+]c and [Ca2+]m responses) in the presence (black, n = 24) or absence (gray, n = 28) of efsevin.
DOI: 10.7554/eLife.04801.024
The following figure supplement is available for figure 5:
Figure supplement 1. Local Ca2+ delivery between IP3 receptors and VDAC2. 
DOI: 10.7554/eLife.04801.025
Figure 5. Continued
healthy looking cells with distinct borders, uniform striations and no membrane blebs or granularity 
were included in the analysis.
Biochemistry
For pull down assays mono-N-Boc protected 2,2'-(ethylenedioxy)bis(ethylamine) was attached to the 
carboxylic ester of efsevin and its derivatives through the amide bond. After removal of the Boc group 
using TFA, the primary amine was coupled to the carboxylic acid of Affi-Gel 10 Gel (Biorad, Hercules, 
CA). 2-day-old zebrafish embryos were deyolked by centrifugation before being lysed with Rubinfeld's 
lysis buffer (Rubinfeld et al., 1993). The lysate was precleaned by incubation with Affi-Gel 10 Gel to 
eliminate non-specific binding. Precleaned lysate was incubated with affinity beads overnight. 
Proteins were eluted from the affinity beads and separated on SDS-PAGE. Protein bands of interest 
were excised. Gel plugs were dehydrated in acetonitrile (ACN) and dried completely in a Speedvac. 
Samples were reduced and alkylated with 10 mM dithiotreitol and 10 mM TCEP solution in 50 mM 
NH4HCO3 (30 min at 56°C) and 100 mM iodoacetamide (45 min in dark), respectively. Gel plugs were 
washed with 50 mM NH4HCO3, dehydrated with ACN, and dried down in a Speedvac. Gel pieces were 
then swollen in digestion buffer containing 50 mM NH4HCO3, and 20.0 ng/μl of chymotrypsin (25°C, 
overnight). Peptides were extracted with 0.1% TFA in 50% ACN solution, dried down and resus-
pended in LC buffer A (0.1% formic acid, 2% ACN).
Mass spectrometry analyses and database searching
Extracted peptides were analyzed by nano-flow LC/MS/MS on a Thermo Orbitrap with dedicated 
Eksigent nanopump using a reversed phase column (New Objective, Woburn, MA). The flow rate 
was 200 nl/min for separation: mobile phase A contained 0.1% formic acid, 2% ACN in water, and 
mobile phase B contained 0.1% formic acid, 20% water in ACN. The gradient used for analyses was 
linear from 5% B to 50% B over 60 min, then to 95% B over 15 min, and finally keeping constant 
95% B for 10 min. Spectra were acquired in data-dependent mode with dynamic exclusion where 
the instrument selects the top six most abundant ions in the parent spectra for fragmentation. Data 
were searched against the Danio rerio IPI database v3.45 using the SEQUEST algorithm in the BioWorks 
software program version 3.3.1 SP1. All spectra used for identification had deltaCN>0.1 and met 
the following Xcorr criteria: >2 (+1), >3 (+2), >4 (+3), and >5 (+4). Searches required full cleavage with 
the enzyme, <4 missed cleavages and were performed with the differential modifications of carbami-
domethylation on cysteine and methionine oxidation.
In situ hybridization
In situ hybridization was performed as previously described (Chen and Fishman, 1996). DIG-labeled 
RNA probe was synthesized using the DIG RNA labeling kit (Roche, Indianapolis, IN).
Immunostaining
HeLa cells were transfected with a C-terminally flag-tagged zebrafish VDAC1 or VDAC2 in plasmid 
pCS2+ using Lipofectamine 2000 (Invitrogen). After staining with MitoTracker Orange (Invitrogen) 
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cells were fixed in 3.7% formaldehyde and permeabilized with acetone. Immunostaining was per-
formed using primary antibody ANTI-FLAG M2 (Sigma Aldrich, St. Luis, MO) at 1:100 and secondary 
antibody Anti-Mouse IgG1-FITC (Southern Biotechnology Associates, Birmingham, AL) at 1:200. Cells 
were mounted and counterstained using Vectashield Hard Set with DAPI (Vector Laboratories, UK).
Mitochondria Ca2+ uptake assay in HeLa cells
HeLa cells were transfected with zebrafish VDAC2 using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). 
36 hrs after transfection, cells were loaded with 5 µM Rhod2-AM (Invitrogen), a Ca2+ indicator preferen-
tially localized in mitochondria, for 1 hr at 15°C followed by a 30 min de-esterification period at 37°C. 
Subsequently, cells were permeabilized with 100 µM digitonin for 1 min at room temperature. 
Figure 6. Effects of efsevin on isolated cardiomyocytes. (A) Electrically paced Ca2+ transients at 0.5 Hz (top). 
Normalized quantification of Ca2+ transient parameters reveals no difference for transient amplitude (efsevin-treated 
at 98.6 ± 4.5% of vehicle-treated) and time to peak (95 ± 3.9%), but a significant decrease for the rate of decay  
(82.8 ± 4% of vehicle- for efsevin-treated) (lower panel). (B) Representation of typical Ca2+ sparks of vehicle- and 
efsevin treated cardiomyocytes (top). No differences were observed for spark frequency (101.1 ± 7.7% for efsevin- 
compared to vehicle-treated), maximum spark amplitude (101.6 ± 2.5%) and Ca2+ release flux (98.7 ± 2.8%). In 
contrast, the decay phase of the single spark was significantly faster in efsevin treated cells (82.5 ± 2.1% of 
vehicle-treated). Consequently, total duration of the spark was reduced to 85.7 ± 2% and the total width was 
reduced to 89.5 ± 1.4% of vehicle-treated cells. *, p < 0.05; ***, p < 0.001. (C) Increasing concentrations of 
extracellular Ca2+ induced a higher frequency of spontaneous propagating Ca2+ waves in isolated adult murine 
ventricular cardiomyocytes. Efsevin treatment reduced Ca2+ waves in a dose-dependent manner. (D) Quantitative 
analysis of spontaneous Ca2+ waves spanning more than half of the entire cell. Addition of 1 µM efsevin reduced 
Ca2+ waves to approximately half. Increasing the concentration of efsevin to 10 µM further reduced the number  
of spontaneous Ca2+ waves and 25 µM efsevin almost entirely blocked the formation of Ca2+ waves.
DOI: 10.7554/eLife.04801.026
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Figure 7. Mitochondria regulate cardiac rhythmicity through a VDAC2-dependent mechanism. (A) MCU and 
MICU1 are expressed in the developing zebrafish hearts (arrowhead). (B) Overexpression of MCU is sufficient to 
restore coordinated cardiac contractions in tre embryos (47.1 ± 1.6% embryos, n = 112 as opposed to 18.3 ± 5.3% 
of uninjected siblings, n = 64) while this effect is significantly attenuated when co-injected with morpholino antisense 
oligonucleotide targeted to VDAC2 (27.1 ± 1.9% embryos, n = 135). (C) Suboptimal overexpression of MCU (MCUS) 
and VDAC2 (VDAC2S) in combination is able to suppress cardiac fibrillation in tre embryos (42.9 ± 2.6% embryos,  
n = 129). (D) The ability of VDAC2 to restore rhythmic contractions in tre embryos (48.5 ± 3.5% embryos, n = 111) is 
significantly attenuated when MCU is knocked down by antisense oligonucleotide (MOMCU) (25.6 ± 2.4% embryos,  
n = 115). (E) Overexpression of MICU1 is sufficient to restore rhythmic cardiac contractions in tre embryos  
(49.3 ± 3.4% embryos, n = 127 compared to 16.8 ± 1.4% of uninjected siblings, n = 150). This effect is abrogated  
by VDAC2 knockdown (MOVDAC2, 25.3 ± 5.5% embryos, n = 97). (F) Suboptimal overexpression of MICU1 (MICU1S) 
and VDAC2 (VDAC2S) in combination is able to restore rhythmic cardiac contractions in tre embryos (48.6 ± 6.0%,  
n = 106). Error bars represent s.d.; *p < 0.05; ***p < 0.001.
DOI: 10.7554/eLife.04801.027
The following figure supplement is available for figure 7:
Figure supplement 1. Expression of MCU, MICU1 and VDAC2. 
DOI: 10.7554/eLife.04801.028
Fluorescence changes in Rhod2 (ex: 544 nm, em: 590 nm) immediately after the addition of Ca2+ (final 
free Ca2+ concentration is calculated to be approximately 10 µM using WEBMAXC at http://web.
stanford.edu/∼cpatton/webmaxcS.htm) were monitored in internal buffer (5 mM K-EGTA, 20 mM 
HEPES, 100 mM K-aspartate, 40 mM KCl, 1 mM MgCl2, 2 mM maleic acid, 2 mM glutamic acid, 
5 mM pyruvic acid, 0.5 mM KH2PO4, 5 mM MgATP, pH adjusted to 7.2 with Trizma base) using a 
FLUOSTAR plate reader (BMG Labtech, Germany).
Mitochondria Ca2+ uptake assay in VDAC1/VDAC3 double knockout 
(V1/V3 DKO) MEFs
V1/V3 DKO MEFs were cultured as previously described (Roy et al., 2009a). Efsevin-treated (15 μM 
for 30 min) or mock-treated MEFs were used for measurements of [Ca2+]c in suspensions of permeabi-
lized cells or imaging of [Ca2+]m simultaneously with [Ca2+]c in intact single cells. Permeabilization of the 
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plasma membrane was performed by digitonin (40 μM/ml). Changes in [Ca2+] in the cytoplasmic buffer 
upon IP3 (7.5 μM) addition in the presence or absence of ruthenium red (3 μM) was measured by fura2 in 
a fluorometer (Csordás et al., 2006; Roy et al., 2009b). To avoid endoplasmic reticulum Ca2+ uptake 
2 μM thapsigargin was added before IP3. For imaging of [Ca2+]m and [Ca2+]c, MEFs were co-transfected 
with plasmids encoding polycistronic zebrafish VDAC2 with mCherry and mitochondria-targeted inverse 
pericam for 40 hr. Cells were sorted to enrich the transfected cells and attached to glass coverslips. In 
the final 10 min, of the efsevin or mock-treatment, the cells were also loaded with fura2AM (2.5 μM) and 
subsequently transferred to the microscope stage. Stimulation with 1 μM ATP was carried out in a normi-
nally Ca2+ free buffer. Changes in [Ca2+]c and [Ca2+]m were imaged using fura2 (ratio of ex:340 nm–380 nm) 
and mitochondria-targeted inverse pericam (ex: 495 nm), respectively (Csordas et al., 2010).
Statistics
All values are expressed as mean ± SEM, unless otherwise specified. Significance values are calculated 
by unpaired student's t-test unless noted otherwise.
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